Pharma & Healthcare News Alsiano No. 22 • June 2016
Contents BENEO secures 2nd authorised 13.5 health claim in 2016 for its chicory root fibres .............1 Vitafoods 2016: news from our suppliers ........3 SEPIFITTM Protect recovery & performance.........5 Micro nutrient mineral blends .....................................6 Jost booklet about minerals...................................6 A natural alternative to support bladder wellness ......7 DNA certified extracts from EPO ................................8 New vegan protein for beverages and bars.................9 New - calcium citrate for chewable tablets ..................10 The Alsiano Healthcare team ......................................10
BENEO secures 2nd authorised 13.5 health claim in 2016 for its chicory root fibres Inulin and oligofructose contribute to a reduction in blood glucose rise By BENEO Starting 20 June, customers working with Orafti® Inulin or Oligofructose can launch products with the following attractive claims: “Lower and more balanced blood glucose rise” or “lower impact on blood glucose levels” in combination with the official EU 13.5. health claim. The official claim wording is as follows: “Consumption of [e.g. breakfast cereals] containing inulin and oligofructose instead of sugars induces a lower blood glucose rise after their consumption compared to sugarcontaining [e.g. breakfast cereals].” This succeeds BENEO’s first 13.5 health claim on digestive health for its chicory inulin which came into force at the beginning of 2016.
Publisher: Alsiano A/S Circulation: 500 copies Editor-in-chief: Anders Hager Coordinator, text, lay-out: Dorthe Andersson Pharma & Healthcare News is published twice a year and distributed to customers and other interested parties. Reproduction of articles appearing in Pharma & Healthcare News requires prior consent of the author. Alsiano is not responsible for the content of articles written by external authors.
1
The recent health claim confirms that inulin and oligofructose contribute to a better blood glucose management as they support a lower rise in blood glucose response. A 30% sugars reduction needs to be obtained by replacement by non-digestible carbohydrates such as BENEO’s inulin and oligofructose according to the conditions of use. The authorisation is based on several scientific studies all of which confirm that oligofructose and inulin have a significant part to play in the area of glycaemic control. About 422 million people worldwide have diabetes, a number that is likely to more than double over the next (continues on page 2 >>)